Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.

Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry

Abstract

Objective To determine if the available data support the use of omega-3 essential fatty acids (EFA) for clinical use in the prevention and/or treatment of psychiatric disorders. Participants The authors of this article were invited participants in the Omega-3 Fatty Acids Subcommittee, assembled by the Committee on Research on Psychiatric Treatments of the American Psychiatric Association (APA). Evidence Published literature and data presented at scientific meetings were reviewed. Specific disorders reviewed included major depressive disorder, bipolar disorder, schizophrenia, dementia, borderline personality disorder and impulsivity, and attention-deficit/hyperactivity disorder. Meta-analyses were conducted in major depressive and bipolar disorders and schizophrenia, as sufficient data were available to conduct such analyses in these areas of interest. Consensus process The subcommittee prepared the manuscript, which was reviewed and approved by the following APA committees: the Committee on Research on Psychiatric Treatments, the Council on Research, and the Joint Reference Committee. Conclusions The preponderance of epidemiologic and tissue compositional studies supports a protective effect of omega-3 EFA intake, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in mood disorders. Meta-analyses of randomized controlled trials demonstrate a statistically significant benefit in unipolar and bipolar depression (p = .02). The results were highly heterogene…

Overview

Integrity signals

Registry

Crossref · 10.4088/jcp.v67n1217

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 118 references

Cited by

See all 715

Metadata

Authors
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., Keck, P. E., Marangell, L. B., Richardson, A. J., Lake, J., & Stoll, A. L.
Affiliations
  • University of Arizona (US)
  • National Institutes of Health (US)
  • University of Pittsburgh (US)
  • University of Maryland, Baltimore (US)
  • Harvard University (US)
  • University of Sheffield (GB)
  • University of Cincinnati (US)
  • United States Department of Veterans Affairs (US)
  • Stanford University (US)
Venue
The Journal of Clinical Psychiatry
Published
2006-12-15
Volume
67
Issue
12
Pages
1954-1967
ISSN
0160-6689 (ISSN-L)
OpenAlex
W1979122474
Cited by
709
References
118
Citations by year
2026: 7 · 2025: 10 · 2024: 14 · 2023: 13 · 2022: 17 · 2021: 16 · 2020: 21 · 2019: 22 · 2018: 25 · 2017: 30 · 2016: 40 · 2015: 47 · 2014: 48 · 2013: 54 · 2012: 51
FWCI
47.20
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5k23at001129-05)
  • National Institute of Mental Health (K23MH066265)
  • National Center for Complementary and Integrative Health (5K23AT001129-05)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
omega-3 fatty acids, eicosapentaenoic acid, docosahexaenoic acid, major depressive disorder, bipolar disorder, schizophrenia, borderline personality disorder, attention deficit hyperactivity disorder, dementia, mood disorders, dietary supplementation, evidence-based treatment recommendations
MeSH terms
Mental Disorders, Humans, Tissue Distribution, Fatty Acids, Omega-3, Epidemiologic Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry. https://app.cochat.ai/papers/10.4088/jcp.v67n1217
The paper
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., Keck, P. E., Marangell, L. B., Richardson, A. J., Lake, J., & Stoll, A. L. (2006). Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v67n1217

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.